Urological Devices | Asia Pacific | 2015 | Market Analysis
The growing aging population in the Asia Pacific region and the increasing use of minimally invasive laser treatments for urinary stones and BPH will drive sales in several segments of this market, thus fueling overall market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in Asia Pacific across a 10-year period.
Surgical procedures that have long been mainstays of urology, such as TURP and radical prostatectomy, will decline in procedure volume in some Asia Pacific countries.
Which countries will see a decline in procedure volumes and why?
What procedures will be performed instead of TURP and radical prostatectomy? How quickly are the volumes of such alternative procedures growing?
What other procedures will see declining use?
The rising adoption of flexible endoscopy in this market will spur growth in multiple device segments.
How many flexible cystoscopes and flexible ureteroscopes will be sold in this region?
How will the stone management device market be impacted by growth in flexible endoscope use?
Will any markets be negatively impacted by the growing use of flexible endoscopy?
The Chinese and Indian markets will grow the fastest among the Asia Pacific countries.
Which indication will see the most growth potential?
How will vaginal sling and PFR procedure volumes in these two countries be impacted by litigation against manufacturers of these devices in other parts of the world?
